Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain

Jesús Troya*, Paul Bastard, Laura Planas-Serra, Pablo Ryan, Montse Ruiz, María de Carranza, Juan Torres, Amalia Martínez, Laurent Abel, Jean-Laurent Casanova, Aurora Pujol

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)914-922
JournalJournal of Clinical Immunology
Volume41
Issue number5
DOIs
Publication statusPublished - 13 Apr 2021

Cite this